New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients

Go back to New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients
(NASDAQ: NRSN) Delayed: 0.70 -0.02 (2.78%)
Previous Close $0.72    52 Week High
Open $0.72    52 Week Low
Day High $0.72    P/E N/A 
Day Low $0.69    EPS
Volume 70,247